Advanced search
Publication Cover
Cancer Management and Research Volume 14, 2022 - Issue
Submit an article Journal homepage
190
Views
0
CrossRef citations to date
0
Altmetric
Original Research

Low MARCO Expression is Associated with Poor Survival in Patients with Hepatocellular Carcinoma Following Liver Transplantation

Qi ZhangOrgan Transplant Center, the First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, 510080, People’s Republic of China
,
Yuxuan WeiOrgan Transplant Center, the First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, 510080, People’s Republic of China
,
Yihu LiOrgan Transplant Center, the First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, 510080, People’s Republic of China
&
Xingyuan JiaoOrgan Transplant Center, the First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, 510080, People’s Republic of ChinaCorrespondence[email protected]
Pages 1935-1944 | Published online: 11 Jun 2022

References

  • Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–249. doi:10.3322/caac.21660
  • Vibert E, Schwartz M, Olthoff KM, et al. Advances in resection and transplantation for hepatocellular carcinoma. J Hepatol. 2020;72(2):262–276. doi:10.1016/j.jhep.2019.11.017
  • Bruix J, Reig M, Sherman M, et al. Evidence-based diagnosis, staging, and treatment of patients with hepatocellular carcinoma. Gastroenterology. 2016;150(4):835–853. doi:10.1053/j.gastro.2015.12.041
  • Fan R, Papatheodoridis G, Sun J, et al. aMAP risk score predicts hepatocellular carcinoma development in patients with chronic hepatitis. J Hepatol. 2020;73(6):1368–1378. doi:10.1016/j.jhep.2020.07.025
  • Bhoori S, Mazzaferro V. Current challenges in liver transplantation for hepatocellular carcinoma. Best Pract Res Clin Gastroenterol. 2014;28(5):867–879. doi:10.1016/j.bpg.2014.08.001
  • Pinna AD, Yang T, Mazzaferro V, et al. Liver transplantation and hepatic resection can achieve cure for hepatocellular carcinoma. Ann Surg. 2018;268(5):868–875. doi:10.1097/SLA.0000000000002889
  • Finn OJ, Mazzaferro V. Cancer immunology. N Engl J Med. 2008;358(25):2704–2715. doi:10.1056/NEJMra072739
  • DeNardo DG, Ruffell B. Macrophages as regulators of tumour immunity and immunotherapy. Nat Rev Immunol. 2019;19(6):369–382. doi:10.1038/s41577-019-0127-6
  • van der Laan LJ, Döpp EA, Haworth R, et al. Regulation and functional involvement of macrophage scavenger receptor MARCO in clearance of bacteria in vivo. J Immunol. 1999;162:939–947.
  • Novakowski KE, Yap NVL, Yin C, et al. l. Human-Specific Mutations and Positively Selected Sites in MARCO Confer Functional Changes. Mol Biol Evol. 2018;35(2):440–450. doi:10.1093/molbev/msx298
  • Matsushita N, Komine H, Grolleau-Julius A, et al. Targeting MARCO can lead to enhanced dendritic cell motility and anti-melanoma activity. Cancer Immunol Immunother. 2010;59(6):875–884. doi:10.1007/s00262-009-0813-5
  • Bergamaschi A, Tagliabue E, Sørlie T, et al. Extracellular matrix signature identifies breast cancer subgroups with different clinical outcome. J Pathol. 2008;214(3):357–367. doi:10.1002/path.2278
  • La Fleur L, Botling J, He F, et al. Targeting MARCO and IL37R on Immunosuppressive Macrophages in Lung Cancer Blocks Regulatory T Cells and Supports Cytotoxic Lymphocyte Function. Cancer Res. 2021;81(4):956–967. doi:10.1158/0008-5472.CAN-20-1885
  • Song K, Kwon H, Han C, et al. Yes-Associated Protein in Kupffer Cells Enhances the Production of Proinflammatory Cytokines and Promotes the Development of Nonalcoholic Steatohepatitis. Hepatology. 2020;72(1):72–87. doi:10.1002/hep.30990
  • Ni M, Zhang J, Sosa R, et al. T-Cell Immunoglobulin and Mucin Domain-Containing Protein-4 Is Critical for Kupffer Cell Homeostatic Function in the Activation and Resolution of Liver Ischemia Reperfusion Injury. Hepatology. 2021;74(4):2118–2132. doi:10.1002/hep.31906
  • Kangas M, Brännström A, Elomaa O, et al. Structure and chromosomal localization of the human and murine genes for the macrophage MARCO receptor. Genomics. 1999;58(1):82–89. doi:10.1006/geno.1999.5811
  • Oscar WH, Yeung S, Ling -C-C, et al. Alternatively activated (M2) macrophages promote tumour growth and invasiveness in hepatocellular carcinoma. J Hepatol. 2015;62(3):607–616. doi:10.1016/j.jhep.2014.10.029
  • Wang -T-T, Yuan J-H, Ma J-Z, et al. CTGF secreted by mesenchymal-like hepatocellular carcinoma cells plays a role in the polarization of macrophages in hepatocellular carcinoma progression. Biomed Pharmacother. 2017;95:111–119. doi:10.1016/j.biopha.2017.08.004
  • Yang Q, Guo N, Zhou Y, et al. The role of tumor-associated macrophages (TAMs) in tumor progression and relevant advance in targeted therapy. Acta Pharm Sin B. 2020;10(11):2156–2170. doi:10.1016/j.apsb.2020.04.004
  • Georgoudaki AM, Prokopec K, Boura V, et al. Reprogramming tumor-associated macrophages by antibody targeting inhibits cancer progression and metastasis. Cell Rep. 2016;15:2000–2011. doi:10.1016/j.celrep.2016.04.084

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.